The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Bristol-Myers Squibb
Outcomes of dasatinib plus intensive chemotherapy or stem cell transplant (SCT) for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) on Children’s Oncology Group AALL0622.
 
William Birdsall Slayton
Consulting or Advisory Role - Jazz Pharmaceuticals
 
John A Kairalla
No Relationships to Disclose
 
Kirk R. Schultz
No Relationships to Disclose
 
Meenakshi Devidas
No Relationships to Disclose
 
Shanjun Helian
No Relationships to Disclose
 
Michael Pulsipher
Consulting or Advisory Role - Novartis
 
Bill H. Chang
No Relationships to Disclose
 
William L. Carroll
No Relationships to Disclose
 
Michael J. Borowitz
No Relationships to Disclose
 
Valerie I. Brown
No Relationships to Disclose
 
Naomi J. Winick
No Relationships to Disclose
 
Andrew J Carroll
No Relationships to Disclose
 
Nyla A. Heerema
No Relationships to Disclose
 
Julie M Gastier-Foster
No Relationships to Disclose
 
Brent L. Wood
No Relationships to Disclose
 
Sherri L. Mizrahy
No Relationships to Disclose
 
Stephen Hunger
Stock and Other Ownership Interests - Amgen; Amgen (I); Express Scripts; Merck (I); Pfizer (I)
Honoraria - Jazz Pharmaceuticals; Sigma-Tau
Patents, Royalties, Other Intellectual Property - I am a co-Inventor on a US patent #8,568,974 B2 Identification of novel subgroups of high-risk pediatric precursor-B acute lymphoblastic leukemia, outcome correlations and diagnostic and therapeutic methods related to same. It has not be licensed and the
Travel, Accommodations, Expenses - Amgen